Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.537 USD | -7.21% | -4.31% | -34.59% |
Business Summary
Number of employees: 179
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Healthcare Services
65.4
%
| 8 | 71.5 % | 8 | 65.4 % | -2.04% |
Product
34.5
%
| 3 | 28.4 % | 4 | 34.5 % | +29.93% |
Corporate
0.1
%
| 0 | 0.0 % | 0 | 0.1 % | +204.94% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 12 | 100.0 % | 13 | 100.0 % | +7.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 17/10/18 | |
Vivek Sethi
DFI | Director of Finance/CFO | 38 | 06/07/23 |
Robert Oliva
PSD | President | 60 | 02-14 |
Joseph M. Chalil
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/21 |
Indrajit Sinha
CTO | Chief Tech/Sci/R&D Officer | - | 23/06/21 |
Chief Operating Officer | 65 | 12/08/14 | |
Treasurer | 43 | 14/03/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Pope
BRD | Director/Board Member | 43 | 25/01/21 |
Chief Operating Officer | 65 | 12/08/14 | |
Sarfaraz Ali
BRD | Director/Board Member | 42 | 29/06/22 |
Chief Executive Officer | 56 | 17/10/18 | |
Alex Flesias
BRD | Director/Board Member | 49 | 25/01/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,054,523 | 17,755,470 ( 93.18 %) | 0 | 93.18 % |
Company contact information
Novo Integrated Sciences, Inc.
11120 NE 2nd Street Suite 100
98004, Bellevue
+
http://novointegrated.comSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.59% | 10.23M | |
+20.79% | 85.64B | |
-28.75% | 70.63B | |
+4.44% | 27.05B | |
-6.19% | 17.97B | |
+1.82% | 17.58B | |
+2.10% | 15.64B | |
+7.06% | 13.55B | |
+10.48% | 13.41B | |
+71.31% | 13.18B |
- Stock Market
- Equities
- NVOS Stock
- Company Novo Integrated Sciences, Inc.